3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
26
Triple Negative Breast Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Adenocarcinoma of Lung
3
Solitary Pulmonary Nodule
1
Rectal Neoplasms
1
Pain, Postoperative
1
Lymphedema
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Breast Cancer Female
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
Saline Solution
7
Dexmedetomidine
5
Bupivacaine
5
Acetaminophen
5
Ropivacaine
4
Lidocaine
4
Morphine
3
Ketamine
3
Control Groups
3
Sodium Chloride
2
Magnesium Sulfate
2
Anesthesia, Spinal
2
salicylhydroxamic acid
1
oxycodone-acetaminophen
1
Transcutaneous Electric Nerve Stimulation
1
Surgical Instruments
1
Respiration
1
Population Groups
1
Oxycodone
1
Ocoxin
1
Nalbuphine
1
Meloxicam
1
Mastectomy, Segmental
1
Ketorolac Tromethamine
1
Ketorolac
1
Injections, Epidural
1
Hydromorphone
1
Hemorrhoidectomy
1
Drainage
1
Dental Occlusion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Postoperative
×
Mastectomy, Segmental
×
1 year
×
Clear all
NCT05876390
2026-04-16
IRACPoP
Niguarda Hospital
Enrolling by invitation
1,500 enrolled